BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32399906)

  • 1. Vaginal laser for overactive bladder syndrome.
    Charalampous I; Tailor VK; Digesu A
    Int Urogynecol J; 2020 Aug; 31(8):1515-1517. PubMed ID: 32399906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective randomized trial comparing the use of tolterodine or weighted vaginal cones in women with overactive bladder syndrome.
    Yüce T; Dökmeci F; Çetinkaya ŞE
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():91-7. PubMed ID: 26720597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Female Urgency, Trial of Urodynamics as Routine Evaluation (FUTURE study): a superiority randomised clinical trial to evaluate the effectiveness and cost-effectiveness of invasive urodynamic investigations in management of women with refractory overactive bladder symptoms.
    Abdel-Fattah M; Chapple C; Guerrero K; Dixon S; Cotterill N; Ward K; Hashim H; Monga A; Brown K; Drake MJ; Gammie A; Mostafa A; Bladder Health UK; Breeman S; Cooper D; MacLennan G; Norrie J
    Trials; 2021 Oct; 22(1):745. PubMed ID: 34702331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of EMG biofeedback assisted pelvic floor muscle therapy on symptoms of the overactive bladder syndrome in women: A randomized controlled trial.
    Voorham JC; De Wachter S; Van den Bos TWL; Putter H; Lycklama À Nijeholt GA; Voorham-van der Zalm PJ
    Neurourol Urodyn; 2017 Sep; 36(7):1796-1803. PubMed ID: 27869312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie JB; Vincent M; Herbison GP; Wilson DI; Wilson D
    Cochrane Database Syst Rev; 2011 Dec; (12):CD005493. PubMed ID: 22161392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
    Dokmeci F; Cetinkaya SE; Seval MM; Dai O
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in managing overactive bladder.
    Araklitis G; Baines G; da Silva AS; Robinson D; Cardozo L
    F1000Res; 2020; 9():. PubMed ID: 32968482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of treatment of overactive bladder syndrome in women.
    Allahdin S; Oo N
    J Obstet Gynaecol; 2012 Apr; 32(3):217-21. PubMed ID: 22369391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Female urinary incontinence: diagnosis and treatment].
    Humburg J
    Ther Umsch; 2019; 73(9):535-540. PubMed ID: 31113313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of refractory overactive bladder.
    Chen LC; Kuo HC
    Low Urin Tract Symptoms; 2019 Sep; 11(4):177-181. PubMed ID: 30900373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overactive bladder: diagnosis and management.
    Robinson D; Cardozo L
    Maturitas; 2012 Feb; 71(2):188-93. PubMed ID: 22197347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overactive bladder syndrome - management and treatment options.
    Arnold J; McLeod N; Thani-Gasalam R; Rashid P
    Aust Fam Physician; 2012 Nov; 41(11):878-83. PubMed ID: 23145420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overactive bladder: not just a normal part of getting older.
    Carpenter L; Campain NJ
    Br J Nurs; 2022 Oct; 31(18):S16-S22. PubMed ID: 36227795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults.
    Alhasso AA; McKinlay J; Patrick K; Stewart L
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003193. PubMed ID: 17054163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent Urinary Tract Infections in Females and the Overlap with Overactive Bladder.
    Nik-Ahd F; Lenore Ackerman A; Anger J
    Curr Urol Rep; 2018 Sep; 19(11):94. PubMed ID: 30215140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical electrical stimulation treatment for overactive bladder: An observational study.
    Yune JJ; Shen JK; Pierce MA; Hardesty JS; Kim J; Siddighi S
    Investig Clin Urol; 2018 Jul; 59(4):246-251. PubMed ID: 29984339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do we need a new definition of the overactive bladder syndrome? ICI-RS 2013.
    Drake MJ
    Neurourol Urodyn; 2014 Jun; 33(5):622-4. PubMed ID: 24838519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of overactive bladder syndrome.
    Srikrishna S; Robinson D; Cardozo L; Vella M
    Postgrad Med J; 2007 Jul; 83(981):481-6. PubMed ID: 17621619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.